MUC4 and MUC5AC as Tumor Markers in Biliary Tract Cancer
Author Information
Author(s): Matull W R, Andreola F, Loh A, Adiguzel Z, Deheragoda M, Qureshi U, Batra S K, Swallow D M, Pereira S P
Primary Institution: The Institute of Hepatology, Royal Free & University College London Medical School
Hypothesis
MUC4 and MUC5AC are tumour-associated mucins in biliary tract cancer (BTC).
Conclusion
Biliary MUC4 and serum MUC5AC are highly specific tumour-associated mucins that may aid in the diagnosis and treatment of biliary tract cancer.
Supporting Evidence
- MUC4 protein was detected in 27% of BTC bile samples.
- MUC5AC was found exclusively in BTC and PSC sera.
- Statistical significance was reached for MUC4 in bile (P<0.01).
- Serum MUC5AC positivity was associated with reduced survival (P=0.03).
- Biliary MUC4 and serum MUC5AC showed high specificity for BTC.
- Median survival for MUC5AC-positive BTC patients was lower than for MUC5AC-negative patients.
Takeaway
Doctors found that certain proteins called MUC4 and MUC5AC can help identify a type of cancer in the bile ducts, which is usually hard to detect.
Methodology
The study assessed MUC4 and MUC5AC expression in bile and serum from 72 patients with biliary obstruction using qPCR and western blot analysis.
Limitations
The study's sensitivity for detecting BTC was relatively low, and the specificity was offset by low sensitivity values.
Participant Demographics
The study included 72 adult patients, with 39 diagnosed with BTC, 8 with non-BTC malignancies, 7 with primary sclerosing cholangitis, and 18 with benign conditions.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 6.4–16.5 months
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website